FR2671554A1 - Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b. - Google Patents

Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b. Download PDF

Info

Publication number
FR2671554A1
FR2671554A1 FR9100273A FR9100273A FR2671554A1 FR 2671554 A1 FR2671554 A1 FR 2671554A1 FR 9100273 A FR9100273 A FR 9100273A FR 9100273 A FR9100273 A FR 9100273A FR 2671554 A1 FR2671554 A1 FR 2671554A1
Authority
FR
France
Prior art keywords
arg
leu
ser
glu
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR9100273A
Other languages
English (en)
French (fr)
Inventor
Somme Gerard
Rietschoten Van Jurphane
Sabatier Jean-Marc
Trepo Christianpicho Christian
Martin Jacques
Tordjeman Marc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clonatec SA
Original Assignee
Clonatec SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clonatec SA filed Critical Clonatec SA
Priority to FR9100273A priority Critical patent/FR2671554A1/fr
Priority to ES92400053T priority patent/ES2042481T1/es
Priority to DE199292400053T priority patent/DE494825T1/de
Priority to EP92400053A priority patent/EP0494825A1/fr
Priority to JP4002647A priority patent/JPH05230097A/ja
Publication of FR2671554A1 publication Critical patent/FR2671554A1/fr
Priority to GR920300134T priority patent/GR920300134T1/el
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9100273A 1991-01-11 1991-01-11 Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b. Withdrawn FR2671554A1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9100273A FR2671554A1 (fr) 1991-01-11 1991-01-11 Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
ES92400053T ES2042481T1 (es) 1991-01-11 1992-01-09 Peptidos sinteticos que derivan del antigeno hbc del virus de la hepatitis b.
DE199292400053T DE494825T1 (de) 1991-01-11 1992-01-09 Synthetische peptide von hepatitis-b-virus-hbc-antigen.
EP92400053A EP0494825A1 (fr) 1991-01-11 1992-01-09 Peptides synthétiques dérivant de l'antigène HBc du virus de l'hépatite B
JP4002647A JPH05230097A (ja) 1991-01-11 1992-01-10 Ｂ型肝炎ウイルスのＨＢｃ抗原由来の合成ペプチド、このウイルスによる感染を検出すること及び抗Ｂ型肝炎ワクチンのための該ペプチドの使用
GR920300134T GR920300134T1 (OSRAM) 1991-01-11 1993-03-16

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100273A FR2671554A1 (fr) 1991-01-11 1991-01-11 Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.

Publications (1)

Publication Number Publication Date
FR2671554A1 true FR2671554A1 (fr) 1992-07-17

Family

ID=9408604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9100273A Withdrawn FR2671554A1 (fr) 1991-01-11 1991-01-11 Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.

Country Status (6)

Country Link
EP (1) EP0494825A1 (OSRAM)
JP (1) JPH05230097A (OSRAM)
DE (1) DE494825T1 (OSRAM)
ES (1) ES2042481T1 (OSRAM)
FR (1) FR2671554A1 (OSRAM)
GR (1) GR920300134T1 (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135209C1 (ru) * 1998-07-17 1999-08-27 Акционерное общество закрытого типа НПК "Комбиотех Лтд" Фармацевтическая композиция для иммунопрофилактики вирусного гепатита b

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1338310A (zh) * 2000-08-10 2002-03-06 清华大学 一种猪瘟病毒表位疫苗及其制备方法
JP3847257B2 (ja) * 2000-08-11 2006-11-22 株式会社先端生命科学研究所 Ｈｂｖの検出又は測定方法
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI82266C (fi) * 1982-10-19 1991-02-11 Cetus Corp Foerfarande foer framstaellning av il-2 -mutein.
US4882145A (en) * 1986-12-09 1989-11-21 Scripps Clinic And Research Foundation T cell epitopes of the hepatitis B virus nucleocapsid protein
ATE198353T1 (de) * 1988-08-24 2001-01-15 American Cyanamid Co Stabilisierung von somatotropinen durch modifikation von cystein-resten durch orts- spezifische mutagenese oder chemische derivatisierung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2135209C1 (ru) * 1998-07-17 1999-08-27 Акционерное общество закрытого типа НПК "Комбиотех Лтд" Фармацевтическая композиция для иммунопрофилактики вирусного гепатита b

Also Published As

Publication number Publication date
ES2042481T1 (es) 1993-12-16
DE494825T1 (de) 1993-01-14
GR920300134T1 (OSRAM) 1993-03-16
EP0494825A1 (fr) 1992-07-15
JPH05230097A (ja) 1993-09-07

Similar Documents

Publication Publication Date Title
Chow et al. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.
JP2682959B2 (ja) エプスタイン・バーウィルス初期抗原（拡散）に関連する合成ポリペプチドおよび抗体
DE3876496T2 (de) Synthetisches peptid-antigen fuer nachweis von hiv-2-infektionen.
JP2573815B2 (ja) マイコバクテリウム感染検出合成ポリペプチド
CA1292839C (en) Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
EP0438332B1 (fr) Peptides dérivant de la glycoprotéine d'enveloppe de virus HIV, leurs applications à la détection d'une infection due à ces virus et à la vaccination contre le SIDA
JPS63501716A (ja) 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
EP0284587A2 (en) Synthetic peptide antigens for the detection of HIV-1 infection
JPH01500432A (ja) Ａｉｄｓおよびａｒｃのウィルス原因物質に対して免疫化するための組成物および方法
JP3356280B2 (ja) 哺乳動物免疫不全ウイルスの検出
LU86972A1 (fr) Anticorps monoclonaux,peptides et compositions les contenant,destinees au diagnostic et au traitement des infections par le virus hiv
AU606595B2 (en) HTLV-III/LAV virus related peptides, antibodies to the peptides, vaccines, passive and active immunization against AIDS virus and diagnostic test for the serological detection of the AIDS virus
EP0750508B1 (fr) RETROPEPTIDES, ANTICORPS DIRIGES CONTRE CES DERNIERS, ET LEURS UTILISATIONS POUR LA VACCINATION ET LE DIAGNOSTIC $i(IN VITRO)
EP0569309B1 (fr) Polypeptides de synthèse appartenant au virus de l'hépatite C (VHC) et utilisables notamment pour détecter ce dernier
Borek et al. Relation between optical configuration and immunogenicity of synthetic polypeptides
FR2671554A1 (fr) Peptides synthetiques derivant de l'antigene hbc du virus de l'hepatite b, leurs applications a la detection d'une infection par ce virus et a la vaccination contre l'hepatite b.
EP0491014B1 (fr) PEPTIDES DE L'ANTIGENE Sm-D ET LEUR UTILISATION NOTAMMENT POUR LE DIAGNOSTIC DU LUPUS ERYTHEMATEUX DISSEMINE
FR2729960A1 (fr) Polypeptides mimotopes de toxoplasma gondii et applications
EP0993616B1 (fr) Reactif de detection et suivi des infections virales
EP0284492A1 (fr) Nouvelles fractions peptidiques inductrices d'anticorps protecteurs contre le virus de la leucémie bovine, procédé pour l'obtention de telles fractions, leurs séquences codantes et vaccins réalisés à partir de ces fractions
WO1989009227A2 (fr) Peptides pf10 a pf19 d'un retrovirus hiv - procede de synthese de ces peptides - leur utilisation notamment pour le diagnostic
FR2682113A1 (fr) Peptides issus de la proteine a de la ribonucleoproteine snrnp-u1 et leur utilisation pour le diagnostic de la connectivite mixte.
FR2657017A1 (fr) Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-1, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
EP0755943A1 (fr) Peptide capable d'être reconnu par des anticorps reconnaissant l'antigène C33 du virus de l'hépatite C
PT91397B (pt) Processo de preparacao de polipeptideos sinteticos e de anticorpos relacionados com o antigenio nuclear do virus de epstein-barr

Legal Events

Date Code Title Description
ST Notification of lapse